STOCK TITAN
  1. Home
  2. FRLN

Freeline Therapeutics Holdings Plc (FRLN) Stock Price, News & Analysis

FRLN NASDAQ

Company Description

Freeline Therapeutics Holdings Plc (NASDAQ: FRLN) is classified in the biological product (except diagnostic) manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for FRLN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
-
-
Last updated:
-
Performance 1 year
-
Market Cap
-
Shares outstanding

Latest News

View All
—

Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

conferences
0.00%

Acquisition of Freeline by Syncona Becomes Effective

+0.31%

Freeline Shareholders Approve Acquisition by Syncona

acquisition
+10.21%

Syncona to Acquire Freeline Therapeutics

acquisition
+1.36%

Freeline Presents Positive New Data from Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease at ESGCT 30th Annual Congress

clinical trial
-0.27%

Freeline Reports Positive Initial Clinical Data from First Cohort of Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease

clinical trial

Freeline Therapeutics Holdings Plc has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 4 with negative movement. Key topics include conferences, acquisition, clinical trial, earnings, earnings date. View all FRLN news →

SEC Filings

View All

No SEC filings available for FRLN.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

FRLN Company Profile & Sector Positioning

Freeline Therapeutics Holdings Plc (FRLN) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.